Background: Breast augmentation is the most common cosmetic surgical procedure in the USA, with nearly 300,000 women undergoing surgery annually. National incidence rates predict that among women undergoing breast augmentation each year, approximately 35,000 will eventually be diagnosed with breast cancer, in particular individual BRCA1/2 germline mutant carriers. Case Report: Our case introduces a novel method of implant coverage after immediate post-mastectomy reconstruction in augmented patients. A novel “capsular flap” (flap of the pre-existing old capsule) is isolated and refolded to cover the outer lower portion of the implant. Conclusion: Tailored surgical approaches can be offered to those patients previously augmented and requiring mastectomy after breast cancer diagnosis.
A New Modality for Breast Cancer Diagnosis During the COVID-19 Pandemic: A Case Report
